El-Sayed MH - Search Results

1

Population Pharmacokinetics of Ledipasvir/Sofosbuvir in Pediatric Patients: Impact of Acute Lymphoblastic Leukemia.

AbdelMagid AM, Abbassi MM, Ebeid FS, El-Sayed MH, Farid SF. AbdelMagid AM, et al. Among authors: el sayed mh. Clin Ther. 2024 Dec 19:S0149-2918(24)00370-9. doi: 10.1016/j.clinthera.2024.11.022. Online ahead of print. Clin Ther. 2024. PMID: 39706761

2

Beta-thalassemia major alters sofosbuvir/ledipasvir exposure in Hepatitis C virus infected adolescent patients.

El-Baraky IA, Abbassi MM, Ebeid FS, Hassany M, Sabry NA, El-Sayed MH. El-Baraky IA, et al. Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101747. doi: 10.1016/j.clinre.2021.101747. Epub 2021 Jun 26. Clin Res Hepatol Gastroenterol. 2021. PMID: 34186262

3

Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancies: A Pharmacokinetic Study.

AbdelMagid AM, Abbassi MM, Ebeid FS, Farid SF, El-Sayed MH. AbdelMagid AM, et al. Clin Ther. 2024 Jan;46(1):e12-e22. doi: 10.1016/j.clinthera.2023.10.007. Epub 2023 Nov 3. Clin Ther. 2024. PMID: 37925363

4

Hepatoprotective efficacy of ursodeoxycholic acid in pediatrics acute lymphoblastic leukemia.

Mohammed Saif M, Farid SF, Khaleel SA, Sabry NA, El-Sayed MH. Mohammed Saif M, et al. Pediatr Hematol Oncol. 2012 Oct;29(7):627-32. doi: 10.3109/08880018.2012.713083. Epub 2012 Aug 13. Pediatr Hematol Oncol. 2012. PMID: 22889151 Clinical Trial.

5

Pharmacokinetics of daclatasvir in Egyptian adolescents with genotype-4 HCV infection.

Al-Nahari MM, Abbassi MM, Ebeid FS, Hassany M, El-Sayed MH, Farid SF. Al-Nahari MM, et al. Antivir Ther. 2020;25(2):101-110. doi: 10.3851/IMP3357. Antivir Ther. 2020. PMID: 32367815

6

The potential hepatoprotective effect of metformin in hepatitis C virus-infected adolescent patients with beta thalassemia major: Randomised clinical trial.

Abdel Monem MS, Farid SF, Abbassi MM, Youssry I, Andraues NG, Hassany M, Selim YMM, El-Sayed MH. Abdel Monem MS, et al. Int J Clin Pract. 2021 Jun;75(6):e14104. doi: 10.1111/ijcp.14104. Epub 2021 Mar 17. Int J Clin Pract. 2021. PMID: 33617679 Clinical Trial.

7

Effective and Safe Daclatasvir Drug Exposures Predicted in Children Using Adult Formulations.

Cressey TR, Abbassi M, Lallemant M, Indolfi G, Al-Nahari M, Farid S, Penazzato M, Easterbrook P, El-Sayed MH. Cressey TR, et al. Pediatr Infect Dis J. 2021 Dec 1;40(12):1081-1086. doi: 10.1097/INF.0000000000003282. Pediatr Infect Dis J. 2021. PMID: 34321444

8

Ledipasvir-sofosbuvir in Adolescents With Chronic Hepatitis C and Hematological Malignancies Undergoing Chemotherapy.

El-Sayed MH, Ebeid FSE, Zekri AR, Massetto B, Kersey K, Zhang F, Gaggar A, Elsayed W, El-Haddad A. El-Sayed MH, et al. J Pediatr Gastroenterol Nutr. 2022 May 1;74(5):626-630. doi: 10.1097/MPG.0000000000003406. Epub 2022 Feb 10. J Pediatr Gastroenterol Nutr. 2022. PMID: 35149641 Clinical Trial.

9

Micro-elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies.

Mostafa A, Ebeid FSE, Khaled B, Ahmed RHM, El-Sayed MH. Mostafa A, et al. Trop Med Int Health. 2020 Jul;25(7):850-860. doi: 10.1111/tmi.13404. Epub 2020 May 29. Trop Med Int Health. 2020. PMID: 32306545 Free article.

10

High Risk of HBV Infection Among Vaccinated Polytransfused Children With Malignancy.

El-Sayed MH, Said ZNA, Abo-Elmagd EK, Ebeid FSE, Salama II. El-Sayed MH, et al. J Pediatr Hematol Oncol. 2021 Jan;43(1):e45-e50. doi: 10.1097/MPH.0000000000001887. J Pediatr Hematol Oncol. 2021. PMID: 32769568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters